Search for: "Mylan Pharmaceuticals v. FDA"
Results 161 - 180
of 233
Sorted by Relevance
|
Sort by Date
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz… [read post]
13 Oct 2014, 9:01 am
Wednesday, the Supreme Court will hold one hour of oral argument on a high-stakes legal battle between a brand-name drug company and a group of companies making generic drugs – Teva Pharmaceuticals USA v. [read post]
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
30 Nov 2021, 9:36 am
Mylan Pharma Inc. [read post]
25 Jan 2007, 12:48 am
Friedlander, 103 F.3d 1105, 1113 (2d Cir. 1997); Mylan Laboratories, Inc. v. [read post]
17 Apr 2012, 5:55 pm
” The Court says that its decision is consistent with the circumstances surrounding the aftermath of the Federal Circuit’s decision in Mylan Pharmaceuticals, Inc. v. [read post]
3 Jun 2016, 6:40 am
Cordis Corporation, et al., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
24 Aug 2011, 12:33 am
: AMP v USPTO (Patent Docs) US: WFU law professor says Federal Circuit failed as “keeper of the Constitution” in AMP v. [read post]
7 Nov 2014, 5:52 am
Millions more use drugs and medical devices even though they carry the FDA’s strongest “black box” warnings. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on… [read post]
10 Jan 2012, 7:58 am
Mylan Pharmaceuticals, Inc., 2011 U.S. [read post]
5 Apr 2012, 11:54 am
Mylan Pharmaceuticals, Inc., ___ F. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
13 Oct 2016, 6:50 am
Lee, No. 16-446 (Eligibility of new use of old manufacture – blackjack game) Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
26 Sep 2022, 4:49 am
Mylan Pharmaceuticals Inc., No. 21-1567 If the Supreme Court grants certiorari in Juno, there is a good chance that it would also hear the parallel written description case of Biogen v. [read post]
27 Aug 2011, 7:55 pm
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) … [read post]
27 May 2011, 8:56 am
Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
